Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCAP.L Regulatory News (CCAP)

  • There is currently no data for CCAP

Appointment

13 Oct 2006 07:01

Charlemagne Capital Limited13 October 2006 13 October 2006 Charlemagne Capital Charlemagne Capital appoints Vicky Kydoniefs as Head of Consultant Relationships Charlemagne Capital Limited, the specialist emerging markets equity investmentmanagement group, is pleased to announce the appointment of Vicky Kydoniefs asHead of Consultant Relationships. Vicky has extensive experience in the institutional investment management field.Before joining Charlemagne Capital, she was with Merrill Lynch InvestmentManagers ("MLIM") in London for 12 years, most recently as Head of UK & IrishInstitutional Business Development. Prior to that she was in charge of thecompany's relationships and sales effort with a number of key consultant firms.Vicky started her career in 1986 with SG Warburg, whose investment managementbusiness was subsequently acquired by MLIM. Julian Mayo, Investment Director commented: "Vicky is widely respected in the pension fund and broader institutional marketplace, an area of increasing importance to Charlemagne Capital. Much of thisbusiness is driven by consultants, an area where she is particularly strong.Vicky will also help us establish best practice in pitching for institutionalbusiness and is an important addition to our team." Enquiries: Charlemagne Capital Tel. 020 7518 2100Julian Mayo, Investment Director Smithfield Consultants Tel. 020 7360 4900John KielyGeorge Hudson Notes to Editors: Charlemagne Capital is a specialist emerging markets equity investmentmanagement group. Charlemagne Capital Limited was admitted to the AIM market ofthe London Stock Exchange on 4 April 2006. Charlemagne's product range comprises mutual funds, hedge funds andinstitutional and specialist fund products primarily covering GEMs, EasternEurope, Latin America and Asia. Charlemagne Capital employs a range ofinvestment strategies including: long only, long/short, structured products andprivate equity. Charlemagne Capital's funds aim to exploit the inefficiencies inthe market via a strict bottom up approach and focused stock selection. Through the strong long-term investment performance track record of itsprincipal funds, Charlemagne Capital has established itself as a market leaderin emerging markets investment management. Its performance has been recognisedthrough numerous awards and top rankings for its funds, including the 2005Standard and Poor's 5-year best performing fund award in Austria, the 2006 SwissLipper Leaders 5-year award winner for Emerging Markets Europe and an AAA-ratingby Standard & Poor's for its Magna Eastern European Fund (a sub-fund of MagnaUmbrella Fund Plc). This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
16th Sep 20217:00 amRNSInterim Results
11th Aug 202112:33 pmRNSResult of AGM
4th Aug 20217:00 amRNSProposed reverse takeover of Smarttech247
16th Jul 20211:00 pmRNSRevised Notice of AGM & Adjournment of AGM
30th Jun 20215:51 pmRNSFinal Results for the year ended 31 December 2020
6th Apr 20217:30 amRNSSuspension - Conduity Capital PLC
1st Apr 20213:45 pmRNSDirector/PDMR Shareholding
31st Mar 20214:28 pmRNSTR-1: Notification of major holdings
30th Mar 202111:38 amRNSTR-1: Notification of major holdings
29th Mar 20214:41 pmRNSSecond Price Monitoring Extn
29th Mar 20214:35 pmRNSPrice Monitoring Extension
29th Mar 20212:05 pmRNSTR-1: Notification of major holdings
29th Mar 20211:48 pmRNSDirector/PDMR Shareholding
25th Mar 20212:00 pmRNSTR-1: Notification of major holdings
25th Mar 202112:47 pmRNSTR-1: Notification of major holdings
24th Mar 20214:41 pmRNSSecond Price Monitoring Extn
24th Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 202111:05 amRNSSecond Price Monitoring Extn
24th Mar 202111:00 amRNSPrice Monitoring Extension
24th Mar 20219:25 amRNSIssue of Equity and Total Voting Rights
24th Mar 20219:05 amRNSSecond Price Monitoring Extn
24th Mar 20219:00 amRNSPrice Monitoring Extension
24th Mar 20217:00 amRNSAIM Rule 15 and Corporate Update
19th Mar 20214:41 pmRNSSecond Price Monitoring Extn
19th Mar 20214:36 pmRNSPrice Monitoring Extension
19th Mar 202111:00 amRNSPrice Monitoring Extension
19th Mar 20219:00 amRNSPrice Monitoring Extension
19th Mar 20218:42 amRNSTR-1: Notification of major holdings
16th Mar 202110:19 amRNSTR-1: Notification of major holdings
15th Mar 20214:41 pmRNSSecond Price Monitoring Extn
15th Mar 20214:35 pmRNSPrice Monitoring Extension
5th Mar 20214:40 pmRNSSecond Price Monitoring Extn
5th Mar 20214:35 pmRNSPrice Monitoring Extension
1st Mar 20218:47 amRNSTR-1: Notification of major holdings
26th Feb 202112:02 pmRNSIssue of Equity and Total Voting Rights
26th Feb 20219:42 amRNSTR-1: Notification of major holdings
22nd Feb 202112:07 pmRNSIssue of Equity and Total Voting Rights
16th Feb 202110:50 amRNSTR-1: Notification of major holdings
8th Feb 20218:38 amRNSIssue of Equity and Total Voting Rights
3rd Feb 202112:51 pmRNSIssue of Equity and Total Voting Rights
3rd Feb 20217:42 amRNSTR-1: Notification of major holdings
1st Feb 202111:04 amRNSIssue of Equity and Total Voting Rights
28th Jan 20214:41 pmRNSSecond Price Monitoring Extn
28th Jan 20214:35 pmRNSPrice Monitoring Extension
28th Jan 20212:06 pmRNSSecond Price Monitoring Extn
28th Jan 20212:00 pmRNSPrice Monitoring Extension
27th Jan 20219:53 amRNSIssue of Equity and Total Voting Rights
26th Jan 20211:53 pmRNSTR-1: Notification of major holdings
25th Jan 20217:50 amRNSTR-1: Notification of major holdings
20th Jan 20213:30 pmRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.